Bristol-Myers Squibb Eliquis Recall Update [US]

US/Silver Spring: Bristol-Myers Squibb updates its existing recall for one (1) batch/lots of Eliquis (apixaban) 5 mg Tablets due to suspected incorrect dosage packaging and consequential failure to protect against serious and life-changing cardiovascular events and/or Death, all serious health hazards. FDA: http://ht.ly/CpHA30cGw9G

Direct link: https://www.fda.gov/Safety/Recalls/ucm563547.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Drugs are subject to this recall:

Bristol-Myers Squibb Eliquis Recall [US]

US/Silver Spring: Bristol-Myers Squibb recalls one batch/lots of Eliquis (apixaban) 5 mg Tablets due to suspected incorrect dosage packaging and consequential failure to protect against serious and life-changing cardiovascular events and/or Death, all serious health hazards. FDA: http://ht.ly/7WzT30cB77V

Direct link: https://www.fda.gov/Safety/Recalls/ucm563002.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Drugs are subject to this recall: